CLOs on the Move


 
Headquartered in Largo, Florida, BioDerm is a leading provider of disposable medical devices and wound care supplies to patients with chronic conditions. BioDerm manufactures proprietary hydrocolloid products for urinary management, securement, infection control and skin protection, challenging accepted inferior standards of care by creating products that reduce infection rates, add comfort and reliability, and vastly improve quality of life. BioDerm`s flagship products for male urinary incontinence are Men`s Liberty for the home setting and Men`s Liberty Acute for in-patient settings. Other products include CathGrip for securement and BioPlus and FreeDerm for skin protection.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Adam Toronto
Vice President of Corporate Compliance Profile

Similar Companies

Chart SeQual Technologies Inc

SeQual is committed to a program of continual improvement and expansion of its air separation product line. We constantly strive to identify new opportunities for on-site gas separation that will benefit our customers by improving or cost-reducing their

Advanced Brain Monitoring

Advanced Brain Monitoring is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Angel Canada Enterprises

Angel Canada Enterprises Ltd. is a Burnaby, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Medstrat

Medstrat is a Downers Grove, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Becton Dickinson

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery` diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology` services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65`000 employees have a passion and commitment to help improve patient outcomes` improve the safety and efficiency of clinicians` care delivery process` enable laboratory scientists to better diagnose disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers` BD can help enhance outcomes` lower costs` increase efficiencies` improve safety and expand access to health care. In 2017` BD welcomed C. R. Bard and its products into the BD family.